Table 3.
Multivariable logistic regression for in-hospital mortality among patients undergoing ERCP (NIS 2016–2022, weighted design; AUC = 0.75)
| Variable | OR (95% CI) | p-value |
|---|---|---|
| Age (per 10-year increase) | 1.51 (1.47–1.54) | < 0.05 |
| Female sex | 0.87 (0.84–0.90) | < 0.05 |
| Type 2 diabetes | 0.87 (0.84–0.90) | < 0.05 |
| Morbid obesity | 0.91 (0.84–0.98) | < 0.05 |
| High-risk comorbidity group | 3.80 (3.66–3.94) | < 0.05 |
| Chronic kidney disease | 1.65 (1.59–1.72) | < 0.05 |
| Chronic heart failure | 2.38 (2.29–2.48) | < 0.05 |
| Liver cirrhosis | 4.53 (4.34–4.73) | < 0.05 |
| Elective admission | 0.86 (0.80–0.93) | < 0.05 |
| Pancreatic cancer | 1.82 (1.74–1.92) | < 0.05 |
| Choledocholithiasis | 1.27 (1.22–1.31) | < 0.05 |
| Chronic pancreatitis | 0.79 (0.72–0.86) | < 0.05 |
| Acute necrotizing pancreatitis | 3.90 (3.52–4.32) | < 0.05 |
| Bile duct perforation | 1.86 (1.34–2.57) | < 0.05 |
| Choleperitonitis | 3.20 (2.70–3.78) | < 0.05 |
| Duct cancer | 2.05 (1.63–2.57) | < 0.05 |